AQXP vs. ZYME, CALT, MBX, ETHZ, SBTX, AVTE, BIOA, NLTX, VIRI, and ELYM
Should you be buying Aquinox Pharmaceuticals stock or one of its competitors? The main competitors of Aquinox Pharmaceuticals include Zymeworks (ZYME), Calliditas Therapeutics AB (publ) (CALT), MBX Biosciences (MBX), Flag Ship Acquisition (ETHZ), Silverback Therapeutics (SBTX), Aerovate Therapeutics (AVTE), BioAge Labs (BIOA), Neoleukin Therapeutics (NLTX), Virios Therapeutics (VIRI), and Eliem Therapeutics (ELYM).
Aquinox Pharmaceuticals vs. Its Competitors
Zymeworks (NASDAQ:ZYME) and Aquinox Pharmaceuticals (NASDAQ:AQXP) are both small-cap pharmaceutical preparations industry companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.
Aquinox Pharmaceuticals has lower revenue, but higher earnings than Zymeworks.
In the previous week, Zymeworks' average media sentiment score of 0.00 equaled Aquinox Pharmaceuticals'average media sentiment score.
Aquinox Pharmaceuticals has a net margin of 0.00% compared to Zymeworks' net margin of -59.96%. Zymeworks' return on equity of -21.59% beat Aquinox Pharmaceuticals' return on equity.
Zymeworks has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Aquinox Pharmaceuticals has a beta of -7.37, indicating that its share price is 837% less volatile than the S&P 500.
92.9% of Zymeworks shares are owned by institutional investors. Comparatively, 71.7% of Aquinox Pharmaceuticals shares are owned by institutional investors. 1.9% of Zymeworks shares are owned by company insiders. Comparatively, 4.0% of Aquinox Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Zymeworks beats Aquinox Pharmaceuticals on 6 of the 10 factors compared between the two stocks.
Get Aquinox Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for AQXP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AQXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aquinox Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:AQXP) was last updated on 10/8/2025 by MarketBeat.com Staff
